⌘K

Login Start Free

Home/Filings/4/0001628280-24-000294

4//SEC Filing

Hasnain Faheem 4

Accession 0001628280-24-000294

CIK 0001576263other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 6:18 PM ET

Size

4.6 KB

Accession

0001628280-24-000294

Insider Transaction Report

Form 4

Period: 2023-12-29

Mirati Therapeutics, Inc.MRTX

Director

Transactions

Award
Common Stock
2023-12-29$58.75/sh+9,702$569,993→ 24,752 total

Footnotes (1)

[F1]Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the anniversary of the grant date.

Documents

1 file

4
wk-form4_1704323893.xmlPrimary
FORM 4

Issuer

Mirati Therapeutics, Inc.

CIK 0001576263

Entity typeother

Related Parties

1

filerCIK 0001352620

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 6:18 PM ET
Size: 4.6 KB

View on SEC.gov